24/7 Market News Snapshot 07 July, 2025 – Cyclacel Pharmaceuticals, Inc (NASDAQ:CYCC)

July 7, 2025

DENVER, Colo., 07 July, 2025 (www.247marketnews.com) – (NASDAQ:CYCC) are discussed in this article.
Cyclacel Pharmaceuticals, Inc. (CYCC) has seen a remarkable surge in its stock value, trading at $3.915, up 10.59% from a previous close of $3.540. This upward momentum has been highlighted by an impressive trading volume of 4.01 million shares, indicating heightened investor interest and suggesting a bullish sentiment surrounding the company. Technical indicators, including the Relative Strength Index (RSI) and moving averages, may further reinforce this trend, positioning CYCC as a stock to monitor closely in the coming sessions.

In a strategic move to bolster its market presence, Cyclacel has announced a significant amendment to its Exchange Agreement with FITTERS Diversified Berhad. The revised agreement will facilitate the exchange of all ordinary shares of FITTERS’ subsidiary, Fitters Sdn. Bhd., for common stock in Cyclacel. This transaction will result in Fitters Sdn. Bhd. becoming a wholly-owned subsidiary of Cyclacel, with Cyclacel issuing shares that represent 19.99% of its outstanding stock as of the closing date, in addition to a $1,000,000 payment to FITTERS.

The boards of both companies have unanimously approved the transaction, which awaits the endorsement of Cyclacel’s stockholders and FITTERS. This partnership is anticipated to create synergies that enhance both entities’ operational capabilities, uniting expertise in innovative safety solutions and cutting-edge cancer therapies. The amendment has also revised the closing date of the transaction to September 30, 2025, providing ample time for necessary approvals and assessments.

Cyclacel remains dedicated to advancing its clinical-stage pipeline focused on combating cancer through pioneering biopharmaceutical endeavors, while Fitters Sdn. Bhd. is recognized for its commitment to quality in the provision of essential safety products. This collaboration is poised to catalyze growth and innovation for both companies, establishing a new frontier in the industry.

Related news for (CYCC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.